These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 22208529)

  • 1. Multiple, ligand-dependent routes from the active site of cytochrome P450 2C9.
    Cojocaru V; Winn PJ; Wade RC
    Curr Drug Metab; 2012 Feb; 13(2):143-54. PubMed ID: 22208529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure and dynamics of the membrane-bound cytochrome P450 2C9.
    Cojocaru V; Balali-Mood K; Sansom MS; Wade RC
    PLoS Comput Biol; 2011 Aug; 7(8):e1002152. PubMed ID: 21852944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiresolution molecular dynamics simulations reveal the interplay between conformational variability and functional interactions in membrane-bound cytochrome P450 2B4.
    Han SB; Teuffel J; Mukherjee G; Wade RC
    Protein Sci; 2024 Oct; 33(10):e5165. PubMed ID: 39291728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New insights into the structural features and functional relevance of human cytochrome P450 2C9. Part II.
    Mo SL; Zhou ZW; Yang LP; Wei MQ; Zhou SF
    Curr Drug Metab; 2009 Dec; 10(10):1127-50. PubMed ID: 20167000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conformational diversity and ligand tunnels of mammalian cytochrome P450s.
    Yu X; Cojocaru V; Wade RC
    Biotechnol Appl Biochem; 2013; 60(1):134-45. PubMed ID: 23587001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flexibility of human cytochrome P450 enzymes: molecular dynamics and spectroscopy reveal important function-related variations.
    Hendrychová T; Anzenbacherová E; Hudeček J; Skopalík J; Lange R; Hildebrandt P; Otyepka M; Anzenbacher P
    Biochim Biophys Acta; 2011 Jan; 1814(1):58-68. PubMed ID: 20656072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural and energetic analysis to provide insight residues of CYP2C9, 2C11 and 2E1 involved in valproic acid dehydrogenation selectivity.
    Bello M; Mendieta-Wejebe JE; Correa-Basurto J
    Biochem Pharmacol; 2014 Jul; 90(2):145-58. PubMed ID: 24794636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavior of human cytochromes P450 on lipid membranes.
    Berka K; Paloncýová M; Anzenbacher P; Otyepka M
    J Phys Chem B; 2013 Oct; 117(39):11556-64. PubMed ID: 23987570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development.
    Zhou SF; Zhou ZW; Yang LP; Cai JP
    Curr Med Chem; 2009; 16(27):3480-675. PubMed ID: 19515014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substrate selectivity of human cytochrome P450 2C9: importance of residues 476, 365, and 114 in recognition of diclofenac and sulfaphenazole and in mechanism-based inactivation by tienilic acid.
    Melet A; Assrir N; Jean P; Pilar Lopez-Garcia M; Marques-Soares C; Jaouen M; Dansette PM; Sari MA; Mansuy D
    Arch Biochem Biophys; 2003 Jan; 409(1):80-91. PubMed ID: 12464247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Membrane position of ibuprofen agrees with suggested access path entrance to cytochrome P450 2C9 active site.
    Berka K; Hendrychová T; Anzenbacher P; Otyepka M
    J Phys Chem A; 2011 Oct; 115(41):11248-55. PubMed ID: 21744854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differing Membrane Interactions of Two Highly Similar Drug-Metabolizing Cytochrome P450 Isoforms: CYP 2C9 and CYP 2C19.
    Mustafa G; Nandekar PP; Bruce NJ; Wade RC
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31487853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New insights into the structural features and functional relevance of human cytochrome P450 2C9. Part I.
    Mo SL; Zhou ZW; Yang LP; Wei MQ; Zhou SF
    Curr Drug Metab; 2009 Dec; 10(10):1075-126. PubMed ID: 20167001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular modeling used to evaluate CYP2C9-dependent metabolism: homology modeling, molecular dynamics and docking simulations.
    Mendieta-Wejebe JE; Correa-Basurto J; García-Segovia EM; Ceballos-Cancino G; Rosales-Hernández MC
    Curr Drug Metab; 2011 Jul; 12(6):533-48. PubMed ID: 21486213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamics of CYP51: implications for function and inhibitor design.
    Yu X; Cojocaru V; Mustafa G; Salo-Ahen OM; Lepesheva GI; Wade RC
    J Mol Recognit; 2015 Feb; 28(2):59-73. PubMed ID: 25601796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of ligand selectivity in CYP3A7 by molecular dynamics simulations.
    Fan JR; Zheng QC; Cui YL; Li WK; Zhang HX
    J Biomol Struct Dyn; 2015; 33(11):2360-7. PubMed ID: 26065334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intramolecular heme ligation of the cytochrome P450 2C9 R108H mutant demonstrates pronounced conformational flexibility of the B-C loop region: implications for substrate binding.
    Roberts AG; Cheesman MJ; Primak A; Bowman MK; Atkins WM; Rettie AE
    Biochemistry; 2010 Oct; 49(40):8700-8. PubMed ID: 20815369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural diversity of human xenobiotic-metabolizing cytochrome P450 monooxygenases.
    Johnson EF; Stout CD
    Biochem Biophys Res Commun; 2005 Dec; 338(1):331-6. PubMed ID: 16157296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. F429 Regulation of Tunnels in Cytochrome P450 2B4: A Top Down Study of Multiple Molecular Dynamics Simulations.
    Mancini G; Zazza C
    PLoS One; 2015; 10(9):e0137075. PubMed ID: 26415031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flexibility of human cytochromes P450: molecular dynamics reveals differences between CYPs 3A4, 2C9, and 2A6, which correlate with their substrate preferences.
    Skopalík J; Anzenbacher P; Otyepka M
    J Phys Chem B; 2008 Jul; 112(27):8165-73. PubMed ID: 18598011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.